EMvision Medical Devices Ltd. (AU:EMV) has released an update.
EMvision Medical Devices Ltd. has announced the cessation of 250,000 options due to unmet conditions, as detailed in their recent ‘Appendix 3H’ filing with the ASX. The options, expiring in December 2025 and priced at $2.25, ceased on March 7, 2024, impacting stakeholders and potentially the company’s capital structure.
For further insights into AU:EMV stock, check out TipRanks’ Stock Analysis page.
